IA
COGT icon

IFP Advisors’s Cogent Biosciences COGT Stock Holding History

IFP Advisors’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$85.6K Buy
2,224
+2,200
+9,167% +$81.2K ﹤0.01% 1946
2025
Q4 		$852 Buy
24
+7
+41% +$197 ﹤0.01% 4119
2025
Q3 		$244 Buy
+17
New +$201 ﹤0.01% 4356
2025
Q2 		– Sell
-8
Closed -$44 – 4083
2025
Q1 		$48 Buy
+8
New +$63 ﹤0.01% 4030
2024
Q4 		– Hold
0
– – – 3236
2023
Q1 		– Sell
-200
Closed -$2K – 3560
2022
Q4 		$2K Hold
200
– – ﹤0.01% 4130
2022
Q3 		$2K Hold
200
– – ﹤0.01% 4331
2022
Q2 		$2K Hold
200
– – ﹤0.01% 4097
2022
Q1 		$2K Buy
+200
New +$1.39K ﹤0.01% 4097

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

IFP Advisors's COGT Position: Q1 2026 in Review

IFP Advisors increased its Cogent Biosciences (COGT) stake by 9,167% in Q1 2026, buying an estimated $81.2K and bringing the position to 2,224 shares worth $85.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1946.

IFP Advisors first reported a position in COGT in Q1 2022 and has held it in 8 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • IFP Advisors held 2,224 shares of Cogent Biosciences worth $85.6K as of Q1 2026.
  • IFP Advisors bought 2,200 Cogent Biosciences shares in Q1 2026, an estimated $81.2K.
  • Cogent Biosciences made up ﹤0.01% of IFP Advisors's portfolio in Q1 2026, its #1946 holding.
  • IFP Advisors first reported a position in Cogent Biosciences in Q1 2022 and has held it in 8 quarters since.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on IFP Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.